|
Originally published In Press as doi:10.1074/jbc.M406153200 on October 12, 2004
J. Biol. Chem., Vol. 279, Issue 53, 55895-55904, December 31, 2004
Biochemical and Cell Biological Analyses of a Mammalian Septin Complex, Sept7/9b/11*
Koh-ichi Nagata ¶,
Tomiko Asano ,
Yoshinori Nozawa||, and
Masaki Inagaki
From the
Department of Molecular Neurobiology, the Institute for Developmental Research, Aichi Human Service Center, 713-8 Kamiya-Cho, Kasugai, Aichi 480-0392, Japan, the Division of Biochemistry, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa, Nagoya 464-8681, ||Gifu International Institute of Biotechnology, 1-1 Nakafudogaoka, Gifu 504-0838, Japan
Septins are members of a conserved family of cytoskeletal GTPases present in organisms as diverse as yeast and mammals. Unlike lower eukaryotic cells, the physiological significance of mammalian septin complexes is largely unknown. Using specific antibodies, we found at least five septins, Sept2, Sept7, Sept8, Sept9b, and Sept11, in septin complexes affinity-purified with anti-Sept7 antibody-conjugated column from rat embryonic fibroblast REF52 cells. Immunofluorescence studies revealed co-localization of Sept7, Sept9b, and Sept11 along stress fibers in REF52 cells. Biochemical and immunoprecipitation analyses revealed that the three septins directly bind with each other through their N- or C-terminal divergent regions. These septins per se formed distinct and characteristic filament structures when transiently expressed in COS7 cells. When two of the three septins were co-expressed in COS7 cells, combination-dependent filament elongation, bundling, or disruption was observed. Taken together, our results suggest that septin filament structures may be affected by interactions with other septins included in the complex.
Received for publication, June 2, 2004
, and in revised form, October 7, 2004.
* This work was supported by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science, Technology, Sports, and Culture of Japan, by a grant-in-aid for the Second Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour, and Welfare, Japan, and by a grant from Yamanouchi Foundation for Research on Metabolic Disorders. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Molecular Neurobiology, The Institute for Developmental Research, Aichi Human Service Center, 713-8 Kamiya-Cho, Kasugai, Aichi 480-0392, Japan. Tel.: 81-568-88-0811 (ext. 3595); Fax: 81-568-88-0829; E-mail: knagata{at}inst-hsc.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Li, D. R. Serwanski, C. P. Miralles, K.-i. Nagata, and A. L. De Blas
Septin 11 Is Present in GABAergic Synapses and Plays a Functional Role in the Cytoarchitecture of Neurons and GABAergic Synaptic Connectivity
J. Biol. Chem.,
June 19, 2009;
284(25):
17253 - 17265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Hannibal, E. K. Ruzzo, L. R. Miller, B. Betz, J. G. Buchan, D. M. Knutzen, K. Barnett, M. L. Landsverk, A. Brice, E. LeGuern, et al.
SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy
Neurology,
May 19, 2009;
72(20):
1755 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mostowy, A. Danckaert, T. N. Tham, C. Machu, S. Guadagnini, J. Pizarro-Cerda, and P. Cossart
Septin 11 Restricts InlB-mediated Invasion by Listeria
J. Biol. Chem.,
April 24, 2009;
284(17):
11613 - 11621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Landsverk, E. K. Ruzzo, H. C. Mefford, K. Buysse, J. G. Buchan, E. E. Eichler, E. M. Petty, E. A. Peterson, D. M. Knutzen, K. Barnett, et al.
Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy
Hum. Mol. Genet.,
April 1, 2009;
18(7):
1200 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Tsang, M. Fedchyshyn, J. Harrison, H. Xie, J. Xue, P. J. Robinson, L.-Y. Wang, and W. S. Trimble
Superfluous Role of Mammalian Septins 3 and 5 in Neuronal Development and Synaptic Transmission
Mol. Cell. Biol.,
December 1, 2008;
28(23):
7012 - 7029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xin, M. Pache, B. Zieger, I. Bartsch, C. Prunte, J. Flammer, and P. Meyer
Septin Expression in Proliferative Retinal Membranes
J. Histochem. Cytochem.,
November 1, 2007;
55(11):
1089 - 1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Low and I. G. Macara
Structural Analysis of Septin 2, 6, and 7 Complexes
J. Biol. Chem.,
October 13, 2006;
281(41):
30697 - 30706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Spiliotis and W. J. Nelson
Here come the septins: novel polymers that coordinate intracellular functions and organization
J. Cell Sci.,
January 1, 2006;
119(1):
4 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ono, M. Ihara, H. Nakajima, K. Ozaki, Y. Kataoka-Fujiwara, T. Taki, K.-i. Nagata, M. Inagaki, N. Yoshida, T. Kitamura, et al.
Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4
Mol. Cell. Biol.,
December 15, 2005;
25(24):
10965 - 10978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Kremer, T. Haystead, and I. G. Macara
Mammalian Septins Regulate Microtubule Stability through Interaction with the Microtubule-binding Protein MAP4
Mol. Biol. Cell,
October 1, 2005;
16(10):
4648 - 4659.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|